Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/06/2019 | ReShape Lifesciences Inc. | OBLN | Purchase | Common Stock | 250k | $4.00 | $1000k | | 08/06/2019 |
08/06/2019 | ReShape Lifesciences Inc. | OBLN | Purchase | Warrants to Purchase Common Stock | 187.5k | $4.40 | $825k | | 08/06/2019 |
08/23/2018 | ReShape Lifesciences Inc. | OBLN | Purchase | Common Stock | 1.6M | $1.82 | $3M | | 08/23/2018 |
03/17/2014 | Achaogen Inc | AKAO | Conversion | Common Stock | 2M | $0.00 | $0 | | 03/17/2014 |
03/17/2014 | Achaogen Inc | AKAO | Conversion | Series B Preferred Stock | 625.1k | $0.00 | $0 | | 03/17/2014 |
03/17/2014 | Achaogen Inc | AKAO | Conversion | Series C Preferred Stock | 926.3k | $0.00 | $0 | | 03/17/2014 |
03/17/2014 | Achaogen Inc | AKAO | Conversion | Series D Preferred Stock | 435.7k | $0.00 | $0 | | 03/17/2014 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Conversion | Common Stock | 3.2M | $0.00 | $0 | | 11/19/2013 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Conversion | Series B Preferred Stock | 356.1k | $0.00 | $0 | | 11/19/2013 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Conversion | Series C Preferred Stock | 549.8k | $0.00 | $0 | | 11/19/2013 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Conversion | Series D Preferred Stock | 2.3M | $0.00 | $0 | | 11/19/2013 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Other (disposition) | Warrant to Purchase Series D Preferred Stock | 590.4k | $4.40 | $2.6M | | 11/19/2013 |
11/19/2013 | TANDEM DIABETES CARE INC | TNDM | Other (acquisition) | Warrant to Purchase Common Stock | 352.4k | $7.37 | $2.6M | | 11/19/2013 |
07/01/2013 | Esperion Therapeutics, Inc. | ESPR | Conversion | Common Stock | 1.8M | $0.00 | $0 | | 07/01/2013 |
07/01/2013 | Esperion Therapeutics, Inc. | ESPR | Purchase | Common Stock | 280.9k | $14.00 | $3.9M | | 07/01/2013 |
07/01/2013 | Esperion Therapeutics, Inc. | ESPR | Conversion | Series A Preferred Stock | 1.8M | $0.00 | $0 | | 07/01/2013 |
07/01/2013 | Esperion Therapeutics, Inc. | ESPR | Other (disposition) | Warrant to Purchase Series A Preferred Stock | 489.3k | $1.00 | $489.3k | | 07/01/2013 |
07/01/2013 | Esperion Therapeutics, Inc. | ESPR | Other (acquisition) | Warrant to Purchase Common Stock | 70k | $6.99 | $489.6k | | 07/01/2013 |
04/15/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 23.2k | $6.62 | $153.7k | | 04/15/2013 |
04/10/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 1.6k | $6.72 | $10.5k | | 04/08/2013 |
04/09/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 11.4k | $6.71 | $76.4k | | 04/08/2013 |
04/08/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 12.2k | $6.52 | $79.7k | | 04/08/2013 |
03/18/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 8k | $5.16 | $41.4k | | 03/15/2013 |
03/15/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 9.6k | $5.28 | $50.9k | | 03/15/2013 |
03/14/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 5k | $5.36 | $26.9k | | 03/13/2013 |
03/13/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 7.7k | $5.40 | $41.8k | | 03/13/2013 |
03/06/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 3.8k | $5.06 | $19.4k | | 03/05/2013 |
03/06/2013 | Clovis Oncology, Inc. | CLVS | Sale | Common Stock | 98.3k | $24.51 | $2.4M | | 03/04/2013 |
03/05/2013 | Clovis Oncology, Inc. | CLVS | Sale | Common Stock | 126.9k | $24.69 | $3.1M | | 03/04/2013 |
03/05/2013 | CADENCE PHARMACEUTICALS INC | CADX | Sale | Common Stock | 4k | $5.01 | $20.2k | | 03/05/2013 |
03/04/2013 | Clovis Oncology, Inc. | CLVS | Sale | Common Stock | 24.8k | $24.44 | $605.7k | | 03/04/2013 |
11/21/2011 | Clovis Oncology, Inc. | CLVS | Conversion | Common Stiock | 409.2k | $0.00 | $0 | | 11/21/2011 |
11/21/2011 | Clovis Oncology, Inc. | CLVS | Conversion | Common Stock | 885.7k | $0.00 | $0 | | 11/21/2011 |
11/21/2011 | Clovis Oncology, Inc. | CLVS | Conversion | Common Stock | 370.8k | $0.00 | $0 | | 11/21/2011 |
11/21/2011 | Clovis Oncology, Inc. | CLVS | Purchase | Common Stock | 916.1k | $13.00 | $11.9M | | 11/21/2011 |
|